588 assets in Acute Myeloid Leukemia

Therapeutic assets addressing Acute Myeloid Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Hydrocortisone Acute Myeloid Leukemia	Children's Oncology Group	P3	B (58)
Mesna Acute Myeloid Leukemia	Center for International Blood and Marrow Transplant Research	P2	B (58)
Montanide Isa 51 Acute Myeloid Leukemia	Sellas Life Sciences Group	P3	B (58)
Orca-T Acute Myeloid Leukemia	Orca Biosystems, Inc.	P3	B (58)
Panobinostat Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P4	B (58)
Pegaspargase Acute Myeloid Leukemia	Janssen Research & Development, LLC	P3	B (58)
Pembrolizumab Acute Myeloid Leukemia	Joanna Yi	P3	B (58)
Ponatinib Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	B (58)
Selinexor Acute Myeloid Leukemia	Donghua Zhang	P3	B (58)
Arsenic Trioxide Acute Myeloid Leukemia	The University of Hong Kong	P3	B (57)
Atorvastatin Acute Myeloid Leukemia	Loyola University	P3	B (57)
Fluconazole Acute Myeloid Leukemia	Bochud Pierre-Yves	P3	B (57)
Itraconazole Acute Myeloid Leukemia	Mansoura University	P2	B (57)
Nadravaleucel Acute Myeloid Leukemia	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P2	B (57)
Nogapendekin Alfa Inbakicept Acute Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (57)
Uproleselan Acute Myeloid Leukemia	National Cancer Institute (NCI)	P3	B (57)
Alpha-Interferon Acute Myeloid Leukemia	Peking University People's Hospital	P4	B (56)
Carboplatin Acute Myeloid Leukemia	Joanna Yi	P2	B (56)
Ciml-Nk Cells Acute Myeloid Leukemia	Children's Hospital Medical Center, Cincinnati	P2	B (56)
Diphenhydramine Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	B (56)
Eltrombopag Acute Myeloid Leukemia	French Innovative Leukemia Organisation	P2/3	B (56)
her2bbζ/cd19t+ t cells Acute Myeloid Leukemia	David Avigan	P1/2	B (56)
Hydroxyurea Acute Myeloid Leukemia	Uma Borate	P2	B (56)
Imgn632 Acute Myeloid Leukemia	AbbVie	P2/3	B (56)
L-Ofloxacin Acute Myeloid Leukemia	University of Manitoba	P3	B (56)
Ruxolitinib Phosphate Acute Myeloid Leukemia	City of Hope Medical Center	P2	B (56)
Sitagliptin Acute Myeloid Leukemia	Indiana University	P2	B (56)
Tagraxofusp Acute Myeloid Leukemia	Jacqueline Garcia, MD	P2	B (56)
Vyxeos Acute Myeloid Leukemia	Jazz Pharmaceuticals	P2/3	B (56)
Motixafortide Acute Myeloid Leukemia	Washington University School of Medicine	P2	CCC (55)
Nerofe Acute Myeloid Leukemia	Immune System Key Ltd	P2	CCC (55)
Nintedanib Acute Myeloid Leukemia	Northwestern University	P2	CCC (55)
Palbociclib Acute Myeloid Leukemia	Thomas Jefferson University	P1/2	CCC (55)
Bleximenib Acute Myeloid Leukemia	Stichting Hemato-Oncologie voor Volwassenen Nederland	P3	CCC (54)
bp1001 Acute Myeloid Leukemia	Bio-Path Holdings, Inc.	P2	CCC (54)
Clifutinib Acute Myeloid Leukemia	Sunshine Lake Pharma Co., Ltd.	P3	CCC (54)
Humanized, Dual-Affinity Re-Targeting, Or (Dart), Molecule That Recognizes Both Cd123 And Cd3 Acute Myeloid Leukemia	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	CCC (54)
Liposomal Cytarabine-Daunorubicin Cpx-351 Acute Myeloid Leukemia	CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.	P3	CCC (54)
Pegfilgrastim Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2/3	CCC (54)
Silybin Acute Myeloid Leukemia	Fujian Medical University Union Hospital	P4	CCC (54)
Vibecotamab Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (54)
Avapritinib Acute Myeloid Leukemia	Ruijin Hospital	P2	CCC (53)
Azd 5991 Acute Myeloid Leukemia	AstraZeneca	P1/2	CCC (53)
Ca-Edta Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (53)
cd45ra-depleted dli Acute Myeloid Leukemia	St. Jude Children's Research Hospital	P2	CCC (53)
Cytokine-Induced Memory-Like Nk Cells Acute Myeloid Leukemia	Washington University School of Medicine	P2	CCC (53)
Decetabine Acute Myeloid Leukemia	Anhui Provincial Hospital	P2	CCC (53)
DMSA Acute Myeloid Leukemia	M.D. Anderson Cancer Center	P2	CCC (53)
Gardasil 9 Vaccine Acute Myeloid Leukemia	Vastra Gotaland Region	P2	CCC (53)
Hyml-122 Acute Myeloid Leukemia	Tarapeutics Science Inc.	P2	CCC (53)

Showing 101 to 150 of 588 assets

PreviousPage 3 of 12Next